Bladder cancer : (Record no. 91902)

MARC details
000 -LEADER
fixed length control field 03604cam a2200565 i 4500
001 - CONTROL NUMBER
control field ocn890934182
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20221128212717.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION
fixed length control field m d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr |||||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 140715t20142014nyua ob 001 0 eng
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
LC control number 2020676542
040 ## - CATALOGING SOURCE
Original cataloging agency DLC
019 ## -
-- 900005799
-- 923676407
-- 928195951
-- 992888218
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9781633216709
Qualifying information (ebook)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 1633216705
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 1633216667
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 9781633216662
035 ## - SYSTEM CONTROL NUMBER
System control number 833073
-- (N$T)
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)890934182
Canceled/invalid control number (OCoLC)900005799
-- (OCoLC)923676407
-- (OCoLC)928195951
-- (OCoLC)992888218
072 #7 - SUBJECT CATEGORY CODE
Subject category code HEA
Subject category code subdivision 039000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 014000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 022000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 112000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 045000
Source bisacsh
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
245 00 - TITLE STATEMENT
Title Bladder cancer :
Subtitle risk factors, emerging treatment strategies and challenges
Statement of responsibility, etc
Medium [E-Book]
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture New York :
Name of producer, publisher, distributor, manufacturer Nova Biomedical/Nova Science Publishers, Inc.,
Date of production, publication, distribution, manufacture, or copyright notice [2014]
300 ## - PHYSICAL DESCRIPTION
Physical description 1 online resource.
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
490 1# - SERIES TITLE
Series statement Cancer etiology, diagnosis and treatments
520 ## - ABSTRACT
Abstract Bladder cancer is the fifth most common form of cancer worldwide and is mainly prevalent in developed countries. It is thought to arise through two distinct pathways: the noninvasive and the invasive. The noninvasive pathway gives rise to a superficial papillary carcinoma that is characterized by activating mutations in oncogenes such as H-ras, FGFR3 and PI3K. This pathway is rarely lethal as superficial papillary carcinomas can be readily removed through transurethral resection. However, 15% of noninvasive urothelial tumors can transform into invasive carcinomas and have high recurrence 80%.--
Assigning source Source other than Library of Congress.
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
590 ## - LOCAL NOTE (RLIN)
Local note Master record variable field(s) change: 050, 082
650 #0 - SUBJECT HEADINGS
Subject term Bladder
General subdivision Cancer.
700 1# - ADDED PERSONAL NAME
Added personal author Haggerty, Samantha,
Relator term editor.
710 2# - ADDED CORPORATE NAME
Added corporate author Nova Biomedical (Publishing company)
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Cancer etiology, diagnosis, and treatments.
856 40 - ONLINE RESOURCE
Uniform Resource Identifier <a href="https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=833073">https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=833073</a>
Link text Kingston Hospital NHS Foundation Trust OpenAthens account holders click here for access
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Suppress in OPAC Do not Suppress in OPAC
588 ## - SOURCE OF DESCRIPTION NOTE
Source of description note Description based on print version record and CIP data provided by publisher.
938 ## -
-- YBP Library Services
-- YANK
-- 11975966
938 ## -
-- EBSCOhost
-- EBSC
-- 833073
938 ## -
-- ebrary
-- EBRY
-- ebr10913185
938 ## -
-- ProQuest Ebook Central
-- EBLB
-- EBL2119877
994 ## -
-- 92
-- N$T
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Shelving location Date acquired Source of acquisition Total Checkouts Date last seen Uniform Resource Identifier Price effective from Koha item type
        Stenhouse Library Stenhouse Library   28/11/2022 eBook EBSCO clinical collection   28/11/2022 https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=833073 28/11/2022 Electronic book
London Health Libraries Koha Consortium privacy notice